Zydus and XOMA Announce IL-2-Based Immuno-Oncology Therapy Licensing Agreement Mar 09, 2020 5:00am EDT
XOMA Reports Third Quarter 2019 Royalty Asset Portfolio Highlights and Financial Results Nov 05, 2019 8:20am EST
XOMA to Present at the H.C. Wainwright 21st Annual Global Investment Conference Sep 03, 2019 8:00am EDT
